Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
Psoriasis is a chronic inflammatory disease characterized by erythematous scaly plaques, accompanied by systemic damage that leads to the development of multiple comorbidities. In particular, the association between psoriasis and cardiometabolic comorbidities, including cardiovascular diseases (CVDs...
Enregistré dans:
Auteurs principaux: | Jiangluyi Cai, Lian Cui, Yu Wang, Ying Li, Xilin Zhang, Yuling Shi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/29eef2a332c8487a99e5fcd26e4944c8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparison of Behavioral Risk Factors and Cardiometabolic Comorbidities of Psoriatic Arthritis and Psoriasis: A Case–Control Study in Chinese Patients
par: Wang Q, et autres
Publié: (2021) -
Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
par: Teklu M, et autres
Publié: (2021) -
Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
par: Landriscina A, et autres
Publié: (2016) -
Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
par: Aalemi AK, et autres
Publié: (2021) -
Psoriasis
par: MOLL LEE,NORMAN
Publié: (1947)